Cargando…
Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway
MATERIALS AND METHODS: A cross-sectional questionnaire study was performed, where 41 ALS patients reported their use of off-label treatments, as well as self-perceived HRQOL using the RAND-12 questionnaire. RESULTS: A majority of respondents used riluzole. Of the 41 respondents, 18 (43.9%) reported...
Autores principales: | Skulstad Johanson, Gard Aasmund, Tysnes, Ole-Bjørn, Bjerknes, Tale L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019451/ https://www.ncbi.nlm.nih.gov/pubmed/35464630 http://dx.doi.org/10.1155/2022/1789946 |
Ejemplares similares
-
Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS) in Norway: Protocol for validation and a prospective cohort study
por: Taule, Tina, et al.
Publicado: (2019) -
Off‐label and unlicensed medicines to hospitalised children in Norway
por: Teigen, Arna, et al.
Publicado: (2016) -
Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis
por: Andersen, Tiina, et al.
Publicado: (2017) -
Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009) -
Anthropometry of Arm: Nutritional Risk Indicator in Amyotrophic Lateral Sclerosis
por: Salvioni, Cristina Cleide dos Santos, et al.
Publicado: (2015)